MENU

PMCUF Stock Pro Medicus (PMCUF, $165) RSI Indicator left the oversold zone on November 12, 2025

A.I.dvisor
at Tickeron.com
Loading...
PMCUF - Pro Medicus, Ltd.
RSI signal
Bullish Trend
Odds of UP Trend
Tickeron
RSI signal
Price: $165
Daily change: +$3.32 (+2.05%)
Daily volume: 995
Capitalization: $17.6B
Industry: Services to the Health Industry

This is a signal that PMCUF's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options. A.I.dvisor looked back and found 23 similar cases where PMCUF's RSI Indicator left the oversold zone, and in of them led to a successful outcome. Odds of Success:

PMCUF in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 31, 2025

PMCUF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where PMCUF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PMCUF's RSI Oscillator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PMCUF advanced for three days, in of 78 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PMCUF as a result. In of 68 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PMCUF turned negative on October 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 34 similar instances when the indicator turned negative. In of the 34 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for PMCUF crossed bearishly below the 50-day moving average on October 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMCUF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PMCUF entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PMCUF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (103.093) is normal, around the industry mean (20.827). P/E Ratio (229.356) is within average values for comparable stocks, (113.023). PMCUF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.450). Dividend Yield (0.002) settles around the average of (0.027) among similar stocks. P/S Ratio (123.457) is also within normal values, averaging (68.870).

View a ticker or compare two or three
PMCUF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
450 Swan Street
Phone
+61 394298800
Employees
76
Web
https://www.promed.com.au